United States Department of Transportation
Evidence Report: Chronic Kidney Disease and Commercial Motor Vehicle Driver Safety
-
2007-11-05
File Language:
English
Details
-
Creators:
-
Corporate Creators:
-
Corporate Contributors:
-
Subject/TRT Terms:
-
DOI:
-
Resource Type:
-
Geographical Coverage:
-
Corporate Publisher:
-
Abstract:The purpose of this evidence report is to address several key questions posed by the Federal Motor Carrier Safety Administration (FMCSA). FMCSA developed each of these key questions so that the answers will provide information useful in updating its current medical examination guidelines. The four key questions addressed in this evidence report are: Key Question 1: Are individuals with kidney disease at an increased risk for a motor vehicle crash? Key Question 2: Are medications used to treat individuals with kidney disease associated with an increased risk of motor vehicle crash among pre-dialysis patients? Key Question 3: Are dialysis and accompanying drug treatments associated with an increased risk of motor vehicle crash? Key Question 4: Are kidney transplantation and accompanying drug treatments associated with an increased crash risk?
-
Format:
-
Funding:
-
Download URL:
-
File Type:
[PDF - 4.10 MB] -
Collection(s):
-
Main Document Checksum:urn:sha-512:70d3f93b11441e56df685894052a188c64005dea3139924266abd8f75964cec0a5f89a243e829ef463179e5585898c44d08040bb5dc17cde2a9c22b5a44d6621
File Language:
English
Found an issue?
ROSA P serves as an archival repository of USDOT-published products including scientific
findings, journal articles, guidelines, recommendations, or other information authored or co-authored by
USDOT or funded partners. As a repository, ROSA P retains documents in their original published format to
ensure public access to scientific information.
You May Also Like
COLLECTION
Federal Motor Carrier Safety Administration